CCCC Buybacks
11 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–11; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| C4 Therapeutics, Inc. | 2026-03-31 | Reported repurchase cash | $200,000.00 |
| C4 Therapeutics, Inc. | 2025-12-31 | Reported repurchase cash | $14,000.00 |
| C4 Therapeutics, Inc. | 2025-03-31 | Reported repurchase cash | $155,000.00 |
| C4 Therapeutics, Inc. | 2024-12-31 | Reported repurchase cash | $0.00 |
| C4 Therapeutics, Inc. | 2024-03-31 | Reported repurchase cash | $109,000.00 |
| C4 Therapeutics, Inc. | 2023-12-31 | Reported repurchase cash | $0.00 |
| C4 Therapeutics, Inc. | 2023-03-31 | Reported repurchase cash | $94,000.00 |
| C4 Therapeutics, Inc. | 2022-12-31 | Reported repurchase cash | $0.00 |
| C4 Therapeutics, Inc. | 2022-03-31 | Reported repurchase cash | $0.00 |
| C4 Therapeutics, Inc. | 2020-12-31 | Reported repurchase cash | -$16,000.00 |
| C4 Therapeutics, Inc. | 2019-12-31 | Reported repurchase cash | -$10,000.00 |